Ajer Jeffrey Robert Insider Trading
Get the latest insider transactions of Ajer Jeffrey Robert. Ajer Jeffrey Robert is Director in NEKTAR THERAPEUTICS ($NKTR) and EVP, Chief Commercial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Chief Commercial Of in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Chief Commercial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN). Discover the current value of Ajer Jeffrey Robert shares.
Address: C/O BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE NOVATO 94949CA
Ajer Jeffrey Robert is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | EVP, Chief Commercial Officer, SVP, Chief Commercial Officer, SVP, Chief Commercial Of | 58,250 | 5,179,007.50 |
| NKTR | NEKTAR THERAPEUTICS | Director | 25,975 | 342,090.75 |
Insider Trading Transactions of Ajer Jeffrey Robert
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Apr 09 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 78.81 | 1,537 | 121,131 | 58,250 |
| Apr 01 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 74.79 | 1,652 | 123,553 | 59,787 |
| Mar 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 76.30 | 1,181 | 90,110 | 61,439 |
| Mar 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 76.30 | 1,181 | 90,110 | 61,439 |
| Mar 23 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 78.52 | 1,513 | 118,801 | 62,620 |
| Mar 19 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 77.99 | 1,308 | 102,011 | 64,133 |
| Mar 19 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 77.99 | 1,308 | 102,011 | 64,133 |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 10,720 | 0 | 72,001 |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 78.39 | 5,273 | 413,350 | 66,728 |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 77.21 | 1,287 | 99,369 | 65,441 |
| Mar 17 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 78.39 | 26,400 | 2,069,496 | 26,400 |
| Oct 15 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 79.91 | 2,121 | 169,489 | 61,281 |
| Sep 30 2020 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sell | 17.25 | 3,250 | 56,063 | 25,975 |
| Sep 30 2020 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sell | 17.25 | 3,250 | 56,063 | 25,975 |
| Sep 24 2020 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Buy | 0.00 | 9,100 | 0 | 29,225 |
| Sep 24 2020 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Option Exercise | 18.91 | 18,200 | 344,162 | 18,200 |
| Sep 21 2020 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sell | 19.74 | 2,250 | 44,415 | 20,125 |
| Jun 23 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 62.59 | 338 | 21,154 | 63,402 |
| Jun 23 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 63.10 | 15,000 | 946,500 | 78,402 |
| Jun 23 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 124.00 | 15,000 | 1,860,000 | 63,402 |
| Jun 23 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 63.10 | 15,000 | 946,500 | 15,700 |
| Apr 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 79.98 | 2,407 | 192,512 | 63,064 |
| Apr 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 79.98 | 2,407 | 192,512 | 63,064 |
| Apr 02 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 82.00 | 1,537 | 126,034 | 65,471 |
| Mar 26 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 74.36 | 2,041 | 151,769 | 68,626 |
| Mar 26 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 78.47 | 1,618 | 126,964 | 67,008 |
| Mar 24 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 73.05 | 3,599 | 262,907 | 70,667 |
| Mar 17 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 84.50 | 7,644 | 645,918 | 63,886 |
| Mar 17 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 10,380 | 0 | 74,266 |
| Mar 17 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 73.82 | 29,590 | 2,184,334 | 29,590 |
| Mar 04 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 9,586 | 0 | 71,530 |
| Oct 01 2019 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sell | 18.06 | 2,375 | 42,893 | 22,375 |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Buy | 0.00 | 6,500 | 0 | 24,750 |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Option Exercise | 18.80 | 13,000 | 244,400 | 13,000 |
| Sep 24 2019 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sell | 20.24 | 2,250 | 45,540 | 18,250 |
| Jun 07 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 68.78 | 309 | 21,254 | 61,994 |
| Jun 06 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 14,160 | 0 | 61,635 |
| Mar 27 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 89.18 | 3,656 | 326,025 | 47,475 |
| Mar 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 88.05 | 3,598 | 316,804 | 51,131 |
| Mar 25 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 89.62 | 2,589 | 232,020 | 56,659 |
| Mar 25 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 90.47 | 1,930 | 174,614 | 54,729 |
| Mar 21 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 93.07 | 3,728 | 346,965 | 59,248 |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 94.53 | 7,169 | 677,686 | 53,606 |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 9,370 | 0 | 62,976 |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 94.53 | 23,450 | 2,216,729 | 23,450 |
| Mar 05 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 12,557 | 0 | 61,692 |
| Mar 05 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 94.76 | 917 | 86,895 | 60,775 |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 63.10 | 9,000 | 567,900 | 58,135 |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 91.62 | 5,201 | 476,494 | 52,934 |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 92.21 | 2,400 | 221,297 | 50,534 |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 93.81 | 799 | 74,957 | 49,735 |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 94.35 | 600 | 56,611 | 49,135 |
| Nov 16 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 63.10 | 9,000 | 567,900 | 30,700 |
| Oct 05 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 98.98 | 1,000 | 98,985 | 49,135 |
| Oct 01 2018 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Buy | 0.00 | 4,750 | 0 | 20,500 |
| Oct 01 2018 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Option Exercise | 60.91 | 9,500 | 578,645 | 9,500 |
| Sep 21 2018 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Sell | 56.76 | 6,750 | 383,130 | 15,750 |
| Jun 13 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 90.31 | 1,436 | 129,685 | 50,135 |
| Jun 06 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 92.07 | 1,414 | 130,187 | 51,571 |
| May 09 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 68.78 | 309 | 21,254 | 53,223 |
| May 09 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 85.96 | 309 | 26,562 | 52,914 |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 80.12 | 2,119 | 169,774 | 52,914 |
| Mar 30 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 79.69 | 1,537 | 122,484 | 55,033 |
| Mar 26 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 81.36 | 3,583 | 291,513 | 56,570 |
| Mar 23 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 83.90 | 4,368 | 366,475 | 60,153 |
| Mar 19 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 83.57 | 3,651 | 305,114 | 51,681 |
| Mar 19 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 12,840 | 0 | 64,521 |
| Mar 19 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 83.57 | 41,040 | 3,429,713 | 41,040 |
| Mar 13 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 82.39 | 2,972 | 244,863 | 55,332 |
| Mar 06 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 79.86 | 1,614 | 128,894 | 58,304 |
| Feb 28 2018 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 12,529 | 0 | 59,918 |
| Sep 26 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 37.46 | 1,355 | 50,758 | 49,299 |
| Sep 26 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 95.00 | 1,355 | 128,725 | 47,944 |
| Sep 26 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 37.46 | 2,166 | 81,138 | 50,110 |
| Sep 26 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 95.00 | 2,166 | 205,770 | 47,944 |
| Sep 26 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 37.46 | 1,355 | 50,758 | 2,166 |
| Sep 26 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 37.46 | 2,166 | 81,138 | 0 |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Buy | 0.00 | 13,500 | 0 | 13,500 |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Buy | 0.00 | 9,000 | 0 | 22,500 |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Option Exercise | 21.75 | 33,750 | 734,063 | 33,750 |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Director | Option Exercise | 21.75 | 22,500 | 489,375 | 22,500 |
| Jun 09 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 89.61 | 1,004 | 89,968 | 47,944 |
| Jun 06 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 90.72 | 1,488 | 134,991 | 48,948 |
| May 17 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 91.50 | 1,096 | 100,284 | 50,436 |
| May 09 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 28.23 | 988 | 27,891 | 52,520 |
| May 09 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 99.00 | 988 | 97,812 | 51,532 |
| May 09 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 38.59 | 3,498 | 134,988 | 55,030 |
| May 09 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 99.00 | 3,498 | 346,302 | 51,532 |
| May 09 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 28.23 | 988 | 27,891 | 0 |
| May 09 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 38.59 | 3,498 | 134,988 | 0 |
| May 04 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 70.30 | 302 | 21,232 | 51,834 |
| May 04 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 96.74 | 302 | 29,215 | 51,532 |
| Mar 31 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 89.15 | 3,890 | 346,794 | 51,532 |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 12,200 | 0 | 55,422 |
| Mar 24 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 87.42 | 39,480 | 3,451,342 | 39,480 |
| Mar 17 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 92.50 | 3,288 | 304,140 | 43,222 |
| Mar 08 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 90.56 | 5,000 | 452,800 | 46,510 |
| Mar 07 2017 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 93.95 | 1,749 | 164,319 | 51,510 |
| Sep 29 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 95.61 | 18,467 | 1,765,648 | 41,342 |
| Jun 07 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 90.00 | 1,488 | 133,920 | 59,809 |
| May 17 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 82.71 | 1,096 | 90,650 | 61,297 |
| May 12 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 80.80 | 679 | 54,863 | 62,393 |
| May 04 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 51.26 | 415 | 21,275 | 63,487 |
| May 04 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Sell | 86.03 | 415 | 35,701 | 63,072 |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Buy | 0.00 | 16,190 | 0 | 63,072 |
| Mar 17 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | EVP, Chief Commercial ... | Option Exercise | 83.43 | 36,280 | 3,026,840 | 36,280 |
| Mar 07 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 89.57 | 2,395 | 214,520 | 48,137 |
| Mar 07 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 88.42 | 1,255 | 110,970 | 46,882 |
| Mar 02 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 81.87 | 17,656 | 1,445,497 | 50,532 |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 0.00 | 6,860 | 0 | 42,465 |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 0.00 | 19,840 | 0 | 62,305 |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 0.00 | 5,883 | 0 | 68,188 |
| Nov 06 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 57.26 | 26 | 1,489 | 35,631 |
| Nov 06 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 117.56 | 26 | 3,057 | 35,605 |
| Jul 22 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 63.10 | 3,000 | 189,300 | 38,605 |
| Jul 22 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 150.00 | 3,000 | 450,000 | 35,605 |
| Jul 22 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 63.10 | 3,000 | 189,300 | 39,700 |
| Jun 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 120.46 | 1,488 | 179,244 | 36,967 |
| Jun 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 122.35 | 1,362 | 166,646 | 35,605 |
| Jun 03 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 125.57 | 413 | 51,860 | 38,832 |
| Jun 03 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 123.76 | 377 | 46,657 | 38,455 |
| May 26 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 126.55 | 1,625 | 205,647 | 39,245 |
| May 19 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 122.78 | 1,096 | 134,567 | 40,870 |
| May 12 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 121.66 | 679 | 82,607 | 41,966 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 51.26 | 943 | 48,341 | 43,033 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 38.59 | 12,502 | 482,452 | 55,535 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.51 | 625 | 13,444 | 56,160 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.51 | 3,125 | 67,219 | 59,285 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 28.23 | 2,642 | 74,584 | 61,927 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 28.23 | 5,258 | 148,433 | 67,185 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 37.46 | 808 | 30,268 | 67,993 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 37.46 | 8,671 | 324,816 | 76,664 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 119.14 | 33,631 | 4,006,794 | 43,033 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 119.20 | 388 | 46,248 | 42,645 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 38.59 | 12,502 | 482,452 | 0 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 21.51 | 625 | 13,444 | 0 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 21.51 | 3,125 | 67,219 | 0 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 28.23 | 2,642 | 74,584 | 978 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 28.23 | 5,258 | 148,433 | 0 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 37.46 | 808 | 30,268 | 1,355 |
| May 08 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 37.46 | 8,671 | 324,816 | 2,166 |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 0.00 | 10,500 | 0 | 42,090 |
| Mar 05 2015 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 108.36 | 23,900 | 2,589,804 | 23,900 |
| Dec 05 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 38.59 | 12,000 | 463,080 | 43,590 |
| Dec 05 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 91.01 | 12,000 | 1,092,161 | 31,590 |
| Dec 05 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 38.59 | 12,000 | 463,080 | 12,502 |
| Nov 05 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 31.26 | 47 | 1,469 | 31,637 |
| Nov 05 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 83.54 | 47 | 3,926 | 31,590 |
| Jun 06 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 0.00 | 11,400 | 0 | 31,590 |
| Jun 06 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 63.10 | 42,700 | 2,694,370 | 42,700 |
| Jun 03 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 57.83 | 377 | 21,804 | 20,190 |
| Jun 02 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 57.96 | 413 | 23,937 | 20,567 |
| May 19 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 56.91 | 1,004 | 57,136 | 20,980 |
| May 16 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 57.44 | 1,096 | 62,954 | 21,984 |
| May 14 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 59.30 | 522 | 30,955 | 23,558 |
| May 14 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 58.18 | 478 | 27,809 | 23,080 |
| May 13 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 57.96 | 621 | 35,992 | 24,080 |
| May 12 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 56.78 | 679 | 38,554 | 24,701 |
| May 05 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 29.70 | 666 | 19,780 | 26,046 |
| May 05 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 59.55 | 666 | 39,661 | 25,380 |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.51 | 2,558 | 55,023 | 27,938 |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 28.23 | 14,812 | 418,143 | 42,750 |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 78.63 | 17,370 | 1,365,831 | 25,380 |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 21.51 | 2,558 | 55,023 | 3,125 |
| Mar 10 2014 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 28.23 | 14,812 | 418,143 | 5,258 |
| Dec 11 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 17.86 | 84 | 1,500 | 14,964 |
| Dec 11 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 14.39 | 3,750 | 53,963 | 18,714 |
| Dec 11 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.51 | 9,192 | 197,720 | 27,906 |
| Dec 11 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 69.55 | 13,026 | 906,010 | 14,880 |
| Dec 11 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 17.86 | 84 | 1,500 | 0 |
| Dec 11 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 14.39 | 3,125 | 44,969 | 0 |
| Dec 11 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 14.39 | 625 | 8,994 | 0 |
| Dec 11 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 21.51 | 9,192 | 197,720 | 625 |
| Nov 05 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 27.91 | 99 | 2,763 | 14,979 |
| Nov 05 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 63.16 | 99 | 6,253 | 14,880 |
| Jun 04 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 62.70 | 297 | 18,622 | 15,373 |
| Jun 04 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 58.34 | 493 | 28,763 | 14,880 |
| May 17 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 0.00 | 8,400 | 0 | 15,670 |
| May 17 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 67.81 | 49,000 | 3,322,690 | 49,000 |
| May 14 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 67.68 | 752 | 50,895 | 8,518 |
| May 14 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 69.26 | 1,248 | 86,431 | 7,270 |
| May 10 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 65.32 | 489 | 31,941 | 10,081 |
| May 10 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 66.00 | 811 | 53,528 | 9,270 |
| May 03 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 23.20 | 797 | 18,490 | 11,367 |
| May 03 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 64.52 | 797 | 51,420 | 10,570 |
| Apr 23 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.51 | 5,000 | 107,550 | 15,570 |
| Apr 23 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 65.00 | 5,000 | 325,000 | 10,570 |
| Apr 23 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 21.51 | 5,000 | 107,550 | 15,500 |
| Mar 06 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.51 | 4,000 | 86,040 | 14,570 |
| Mar 06 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 60.00 | 4,000 | 240,000 | 10,570 |
| Mar 06 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 21.51 | 4,000 | 86,040 | 20,500 |
| Jan 24 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.51 | 3,000 | 64,530 | 13,570 |
| Jan 24 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 55.00 | 3,000 | 165,000 | 10,570 |
| Jan 24 2013 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 21.51 | 3,000 | 64,530 | 93,034 |
| Nov 30 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 14.39 | 2,500 | 35,975 | 13,070 |
| Nov 30 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 17.86 | 916 | 16,360 | 13,986 |
| Nov 30 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.51 | 2,500 | 53,775 | 16,486 |
| Nov 30 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 48.31 | 5,916 | 285,817 | 10,570 |
| Nov 30 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 14.39 | 2,500 | 35,975 | 99,450 |
| Nov 30 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 17.86 | 916 | 16,360 | 98,534 |
| Nov 30 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Option Exercise | 21.51 | 2,500 | 53,775 | 96,034 |
| Nov 14 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Buy | 21.76 | 265 | 5,766 | 10,835 |
| Nov 14 2012 | BMRN | BIOMARIN PHARMACEUTICAL I ... | Ajer Jeffrey Robert | SVP, Chief Commercial ... | Sell | 48.11 | 265 | 12,750 | 10,570 |